SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001104659-19-075336
Filing Date
2019-12-23
Accepted
2019-12-23 09:10:13
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B3 tm1927288d1_424b3.htm 424B3 39380
2 GRAPHIC image_001.jpg GRAPHIC 5267
  Complete submission text file 0001104659-19-075336.txt   47820
Mailing Address 7 CLARKE DRIVE CRANBURY NJ 08512
Business Address 7 CLARKE DRIVE CRANBURY NJ 08512 6096193990
Outlook Therapeutics, Inc. (Filer) CIK: 0001649989 (see all company filings)

IRS No.: 383982704 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 424B3 | Act: 33 | File No.: 333-229761 | Film No.: 191303586
SIC: 2836 Biological Products, (No Diagnostic Substances)